SA
CLBT logo
Cellebrite DI Ltd.(CLBT)
Closing price · checked 8:20 PM ETAbout this dataData status
$10.77▼-0.55 (-4.86%)
Extended:$11.23+0.46 (+4.27%)· 8:20 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Cellebrite DI Ltd. (CLBT)

R&D to Revenue

23.94%

Fiscal year · Period ending:

CLBT logo

CLBT R&D to Revenue

Latest reported23.94%
CLBT FY R&D/Revenue (27.10% → 23.94%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

CLBT r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Cellebrite DI Ltd. R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
23.9401%−0.59 pts
24.53%−1.43 pts
25.9561%−3.83 pts
29.7874%+3.17 pts
26.6161%−1.28 pts
27.8981%+0.80 pts
27.1003%—

Frequently asked questions: CLBT r&d to revenue

What is Cellebrite DI Ltd. (CLBT)'s current r&d to revenue?

Cellebrite DI Ltd. (CLBT)'s latest reported r&d to revenue (Fiscal year) is 23.94% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for CLBT?

Stock Alarm Pro provides 7 dated annual fiscal periods observations for Cellebrite DI Ltd. (CLBT)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare CLBT's r&d to revenue to peers or set an alert?

You can open CLBT's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on CLBT delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.